And all of a sudden a No 3 bus comes along (Croxted Road
), making that statement wrong.
MHRA: Ronapreve is indicated for the prophylaxis and treatment of acute Covid-19 infection. The medicine is a mix of "Casirivimab and imdevimab: two neutralising IgG1 recombinant human monoclonal antibodies produced by recombinant DNA technology in Chinese hamster [
] ovary cells".
Looks like the prophylaxis target are individuals with mild or moderate renal impairment or with mild hepatic impairment who may or may not be able to take the vaccine.